Analysis of adverse drug reactions in 507 cases of Tislelizumab: A real-world retrospective study based on data from Guangxi, China

• Shaohuan Lu,

  Roles Writing – original draft

  Affiliation Department of Pharmacy, The First People’s Hospital of Yulin, Yulin, Guangxi, China

  ⨯
• Dajian Chen,

  Roles Data curation

  Affiliation Adverse Drug Reaction Monitoring Office, Yulin Food and Drug Inspection and Testing Center, Yulin, Guangxi, China

  ⨯
• Yang Li,

  Roles Formal analysis

  Affiliation Department of Pharmacy, The First People’s Hospital of Yulin, Yulin, Guangxi, China

  ⨯
• Qianxi Chen ,

  Contributed equally to this work with: Qianxi Chen, Guangyi Meng

  Roles Writing – review & editing

  * E-mail: ylsymgy@163.com (GYM); wonderfulqx@163.com (QXC)

  Affiliation Department of Pharmacy, The First People’s Hospital of Yulin, Yulin, Guangxi, China

  ⨯
• Guangyi Meng

  Contributed equally to this work with: Qianxi Chen, Guangyi Meng

  Roles Writing – review & editing

  * E-mail: ylsymgy@163.com (GYM); wonderfulqx@163.com (QXC)

  Affiliation Department of Pharmacy, The First People’s Hospital of Yulin, Yulin, Guangxi, China

  https://orcid.org/0009-0007-3240-5191

  ⨯